scispace - formally typeset
T

Thomas Schlöglhofer

Researcher at Medical University of Vienna

Publications -  82
Citations -  836

Thomas Schlöglhofer is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Ventricular assist device & Medicine. The author has an hindex of 12, co-authored 54 publications receiving 471 citations. Previous affiliations of Thomas Schlöglhofer include University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

The 2018 ISHLT/APM/AST/ICCAC/STSW Recommendations for the Psychosocial Evaluation of Adult Cardiothoracic Transplant Candidates and Candidates for Long-term Mechanical Circulatory Support

TL;DR: The recommendations are intended to dovetail with current ISHLT guidelines and consensus statements for the selection of candidates for cardiothoracic transplantation and MCS implantation and are designed to promote consistency across programs in the performance of the psychosocial evaluation.
Journal ArticleDOI

Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot Trial.

TL;DR: In this article, a randomized controlled trial of dabigatran versus phenprocoumon in left ventricular assist device patients was conducted and the study was stopped prematurely for safety reasons after 16 patients (61±8 years, 1 female) were randomized.
Journal ArticleDOI

Semi-invasive measurement of cardiac output based on pulse contour: a review and analysis

TL;DR: A meta-analysis of all five of the most popular systems for arterial pulse contour analysis compared with pulmonary artery thermodilution, the established reference method for measuring cardiac output, indicates that the calibrated systems seem to deliver more accurate measurements than the auto-Calibrated or the non-calibrated systems.
Journal ArticleDOI

Prevention and early treatment of driveline infections in ventricular assist device patients - The DESTINE staging proposal and the first standard of care protocol.

TL;DR: Broad consensus was reached on the fact that an interdisciplinary approach both in DLES care and DLES healing disorder awareness is required to prolong infect-free survival times on MCS as well as to ensure high patient compliance and quality of life.